請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40117
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫(Bor-Luen Chiang) | |
dc.contributor.author | Wen-Jan Chiang | en |
dc.contributor.author | 姜文然 | zh_TW |
dc.date.accessioned | 2021-06-14T16:41:27Z | - |
dc.date.available | 2018-07-31 | |
dc.date.copyright | 2008-09-11 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-08-01 | |
dc.identifier.citation | Apostolou, I., Sarukhan, A., Klein, L., and von Boehmer, H. (2002). Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3, 756-763.
Bacchetta, R., Bigler, M., Touraine, J.L., Parkman, R., Tovo, P.A., Abrams, J., de Waal Malefyt, R., de Vries, J.E., and Roncarolo, M.G. (1994). High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179, 493-502. Bacchetta, R., Sartirana, C., Levings, M.K., Bordignon, C., Narula, S., and Roncarolo, M.G. (2002). Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32, 2237-2245. Barrat, F.J., Cua, D.J., Boonstra, A., Richards, D.F., Crain, C., Savelkoul, H.F., de Waal-Malefyt, R., Coffman, R.L., Hawrylowicz, C.M., and O'Garra, A. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195, 603-616. Battaglia, M., Gianfrani, C., Gregori, S., and Roncarolo, M.G. (2004). IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 1029, 142-153. Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27, 20-21. Boden, E., Tang, Q., Bour-Jordan, H., and Bluestone, J.A. (2003). The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found Symp 252, 55-63; discussion 63-56, 106-114. Bodor, J., Fehervari, Z., Diamond, B., and Sakaguchi, S. (2007). ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur J Immunol 37, 884-895. Brightbill, H.D., Plevy, S.E., Modlin, R.L., and Smale, S.T. (2000). A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol 164, 1940-1951. Bruder, D., Probst-Kepper, M., Westendorf, A.M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., and Hansen, W. (2004). Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 34, 623-630. Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27, 68-73. Buckner, J.H., and Ziegler, S.F. (2004). Regulating the immune system: the induction of regulatory T cells in the periphery. Arthritis Res & Ther 6, 215-222. Chang, H., Brown, C.W., and Matzuk, M.M. (2002). Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 23, 787-823. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., and Wahl, S.M. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198, 1875-1886. Chen, W., Jin, W., Tian, H., Sicurello, P., Frank, M., Orenstein, J.M., and Wahl, S.M. (2001). Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med 194, 439-453. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., and Weiner, H.L. (1994). Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240. Chung, E.J., Choi, S.H., Shim, Y.H., Bang, Y.J., Hur, K.C., and Kim, C.W. (2000). Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1-like protease. Cell Immunol 204, 46-54. Cottrez, F., and Groux, H. (2004). Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation 77, S12-15. Davidson, T.S., DiPaolo, R.J., Andersson, J., and Shevach, E.M. (2007). Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178, 4022-4026. Derynck, R., and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584. Duthoit, C.T., Nguyen, P., and Geiger, T.L. (2004). Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells. J Immunol 172, 2238-2246. Engel, M.E., McDonnell, M.A., Law, B.K., and Moses, H.L. (1999). Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274, 37413-37420. Fantini, M.C., Becker, C., Monteleone, G., Pallone, F., Galle, P.R., and Neurath, M.F. (2004). Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172, 5149-5153. Fantini, M.C., Dominitzki, S., Rizzo, A., Neurath, M.F., and Becker, C. (2007). In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat Protoc 2, 1789-1794. Finbloom, D.S., and Winestock, K.D. (1995). IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 155, 1079-1090. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336. Genestier, L., Kasibhatla, S., Brunner, T., and Green, D.R. (1999). Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med 189, 231-239. Gershon, R.K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737. Gondek, D.C., Lu, L.F., Quezada, S.A., Sakaguchi, S., and Noelle, R.J. (2005). Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 174, 1783-1786. Gonzalez-Rey, E., Chorny, A., O'Valle, F., and Delgado, M. (2007). Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. Am J Pathol 170, 263-271. Gorelik, L., Constant, S., and Flavell, R.A. (2002). Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195, 1499-1505. Gorelik, L., and Flavell, R.A. (2002). Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2, 46-53. Govinden, R., and Bhoola, K.D. (2003). Genealogy, expression, and cellular function of transforming growth factor-beta. Pharmacol Ther 98, 257-265. Gray, J.D., Liu, T., Huynh, N., and Horwitz, D.A. (2001). Transforming growth factor beta enhances the expression of CD154 (CD40L) and production of tumor necrosis factor alpha by human T lymphocytes. Immunol Lett 78, 83-88. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J.E., and Roncarolo, M.G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. Heath, V.L., Murphy, E.E., Crain, C., Tomlinson, M.G., and O'Garra, A. (2000). TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 30, 2639-2649. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061. Huang, C.T., Workman, C.J., Flies, D., Pan, X., Marson, A.L., Zhou, G., Hipkiss, E.L., Ravi, S., Kowalski, J., Levitsky, H.I., et al. (2004). Role of LAG-3 in regulatory T cells. Immunity 21, 503-513. Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., and D'Ambrosio, D. (2001). Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194, 847-853. Inman, G.J., Nicolas, F.J., and Hill, C.S. (2002). Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10, 283-294. Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., and Sakaguchi, S. (1999). Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162, 5317-5326. Johnson, K., Kirkpatrick, H., Comer, A., Hoffmann, F.M., and Laughon, A. (1999). Interaction of Smad complexes with tripartite DNA-binding sites. J Biol Chem 274, 20709-20716. Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4, 337-342. Kim, J.M., and Rudensky, A. (2006). The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 212, 86-98. Kotenko, S.V., Krause, C.D., Izotova, L.S., Pollack, B.P., Wu, W., and Pestka, S. (1997). Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16, 5894-5903. Lee, H.M., and Rich, S. (1993). Differential activation of CD8+ T cells by transforming growth factor-beta 1. J Immunol 151, 668-677. Levings, M.K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., and Roncarolo, M.G. (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166, 5530-5539. McHugh, R.S., Whitters, M.J., Piccirillo, C.A., Young, D.A., Shevach, E.M., Collins, M., and Byrne, M.C. (2002). CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323. Miller, A., Lider, O., Roberts, A.B., Sporn, M.B., and Weiner, H.L. (1992). Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 89, 421-425. Mills, K.H. (2004). Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4, 841-855. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765. Moore, K.W., Vieira, P., Fiorentino, D.F., Trounstine, M.L., Khan, T.A., and Mosmann, T.R. (1990). Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248, 1230-1234. Mosmann, T.R., and Coffman, R.L. (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145-173. Mottet, C., and Golshayan, D. (2007). CD4+CD25+Foxp3+ regulatory T cells: from basic research to potential therapeutic use. Swiss Med Wkly 137, 625-634. Nishizuka, Y., and Sakakura, T. (1969). Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753-755. Rodig, S.J., Meraz, M.A., White, J.M., Lampe, P.A., Riley, J.K., Arthur, C.D., King, K.L., Sheehan, K.C., Yin, L., Pennica, D., et al. (1998). Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373-383. Sakaguchi, S. (2008). Regulatory T cells in the past and for the future. Eur J Immunol 38, 901-937. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., and Nomura, T. (2006). Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212, 8-27. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164. Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., and Bluestone, J.A. (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440. Sansom, D.M., and Walker, L.S. (2006). The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212, 131-148. Shevach, E.M. (2000). Regulatory T cells in autoimmmunity. Annu Rev Immunol 18, 423-449. Shevach, E.M. (2002). CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2, 389-400. Shi, Y., Wang, Y.F., Jayaraman, L., Yang, H., Massague, J., and Pavletich, N.P. (1998). Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94, 585-594. Sillett, H.K., Cruickshank, S.M., Southgate, J., and Trejdosiewicz, L.K. (2001). Transforming growth factor-beta promotes 'death by neglect' in post-activated human T cells. Immunology 102, 310-316. Sugimoto, N., Oida, T., Hirota, K., Nakamura, K., Nomura, T., Uchiyama, T., and Sakaguchi, S. (2006). Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 18, 1197-1209. Suri-Payer, E., Amar, A.Z., Thornton, A.M., and Shevach, E.M. (1998). CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160, 1212-1218. Suto, A., Nakajima, H., Ikeda, K., Kubo, S., Nakayama, T., Taniguchi, M., Saito, Y., and Iwamoto, I. (2002). CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood 99, 555-560. Tang, Q., Boden, E.K., Henriksen, K.J., Bour-Jordan, H., Bi, M., and Bluestone, J.A. (2004). Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol 34, 2996-3005. Thornton, A.M., Donovan, E.E., Piccirillo, C.A., and Shevach, E.M. (2004). Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172, 6519-6523. Tone, M., Powell, M.J., Tone, Y., Thompson, S.A., and Waldmann, H. (2000). IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 165, 286-291. Veldman, C., Hohne, A., Dieckmann, D., Schuler, G., and Hertl, M. (2004). Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 172, 6468-6475. Vieira, P., de Waal-Malefyt, R., Dang, M.N., Johnson, K.E., Kastelein, R., Fiorentino, D.F., deVries, J.E., Roncarolo, M.G., Mosmann, T.R., and Moore, K.W. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 88, 1172-1176. Wan, Y.Y., and Flavell, R.A. (2006). The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 212, 114-130. Weiner, H.L. (2001a). Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182, 207-214. Weiner, H.L. (2001b). Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 3, 947-954. Wildin, R.S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27, 18-20. Wu, K., Bi, Y., Sun, K., and Wang, C. (2007). IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 4, 269-275. Yi, H., Zhen, Y., Jiang, L., Zheng, J., and Zhao, Y. (2006). The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell Mol Immunol 3, 189-195. Yu, L., Hebert, M.C., and Zhang, Y.E. (2002). TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21, 3749-3759. Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler, K.W., Vogelstein, B., and Kern, S.E. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1, 611-617. Zhang, X., Izikson, L., Liu, L., and Weiner, H.L. (2001). Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 167, 4245-4253. Zheng, S.G., Wang, J., Wang, P., Gray, J.D., and Horwitz, D.A. (2007). IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178, 2018-2027. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40117 | - |
dc.description.abstract | 目前廣泛地認知在人類和齧齒類動物中有一群被命名為”調節性T細胞”的細胞族群具有調節免疫反應的能力,來維持自體耐受性和免疫系統的體內平衡。在過去幾年內,免疫學者研究指出在CD4+CD25+調節性T細胞裡,除了CD25分子標記外,還發現轉錄因子Foxp3在此種T細胞裡扮演著關鍵的角色,無論如何現今仍存在著許多關於這些調節性T細胞發育、分化和作用機轉,甚至是調節性T細胞彼此之間相互影響的問題等待解決。
因此在本實驗當中,我們使用帶有IL-10基因之重組慢病毒系統來感染T細胞,使得T細胞會大量表現IL-10基因並且轉變成為一種”類第一型調節性T細胞”,接著利用DNA微陣列晶片技術來進行基因表現分析,並且加以比較我們實驗室另外兩種以同樣系統表現Foxp3和TGF-β基因之微陣列晶片的結果進行綜合分析,進一步地挑選出標的基因進行實驗,觀察它們在活化或未活化的調節性T細胞裡的基因表現,另外我們從BALB/c小鼠中取出CD4+ T細胞和細胞激素TGF-β一起繼代培養,在加入TGF-β後的CD4+ T細胞可引起轉錄因子Foxp3之表現,轉變成為一種週邊誘導型調節性T細胞,並且同樣地去觀察標的基因在此種調節性T細胞裡的表現。 在我們初步分析微陣列晶片的結果中發現共有37個基因各自在兩種晶片的結果裡顯示有表現,經過篩選後挑出11個受到我們注意並想要進一步研究的基因,有Gsk3b, Ogt, Dub1, Ptprj, Ccr2, Lck, Icos, Ptprk, Slc2a1, Adm 和 Crem,另外值得注意的是我們發現其中在Foxp3和TGF-β基因之晶片結果當中各自有個具高度表現的基因,目前在一些研究中被認為可能是調節性T細胞的專一性標記,分別是Gzmb 和 Nkg7基因,然而在這些初步的分析結果後,還有待我們進一步地研究這些基因和調節性T細胞之間的關係。 | zh_TW |
dc.description.abstract | It is widely known that a population of T cells named “regulatory T cells” (Tregs) might control the immune response in humans and rodents, maintain the self-tolerance and immune homeostasis. For the past few years, except for the surface marker CD25, immunologists found Foxp3 to be the key master factor in naturally occurring CD4+CD25+ T cells. However, there still have many questions about development, differentiation and mechanisms in the subset of Tregs even including their interaction between each other that need to be answered.
Therefore, in our study, we exploited lentivirus system carrying IL-10 gene to infect T cells. Making T cells over-express IL-10 gene and converted it into an IL-10-secreting Tr1-like T cell. Following that, we used the DNA microarray technique for gene analysis and compared with the data of Foxp3- and TGF-β-transduced T cells in our laboratory, then selected some target genes for examination of gene expression both in fresh and activated Treg compared with non-Treg. In addition, we isolated naïve T cells (CD4+CD25-) from BALB/c mice and treated in the presence of TGF-β in vitro and the cells can be induced to express Foxp3, converted it into peripheral inducible Treg. We also investigated gene expression of the target genes in these TGF-β-derived Foxp3+ T cells. In our basic finding, there were 37 genes expression in both of the microarray data, and we narrowed down to 11 genes which we interest and further investigate, such as Gsk3b, Ogt, Dub1, Ptprj, Ccr2, Lck, Icos, Ptprk, Slc2a1, Adm and Crem. Notably, we also found that the two genes were highly expressed in the data of Foxp3- and TGF-β-transduced T cells, and have been considered as specific markers of natural Treg in several reports, such as Gzmb and Nkg7. However, there is still needed to further investigate the relationship between these genes and nTreg. | en |
dc.description.provenance | Made available in DSpace on 2021-06-14T16:41:27Z (GMT). No. of bitstreams: 1 ntu-97-R95450009-1.pdf: 3353111 bytes, checksum: fd4bce6fda7d513d03514bfdd1b1d193 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | Contents
口試委員會審定書........................................................................................................i 誌謝…………………………………………………………………………………....ii 中文摘要…………………………………………………………………...…...……..iv Abstract………………………………………………………………………..……...vi Contents………………………………………………………………………..……...viii Contents of Figures and Tables....................................................................................ix Chapter Ⅰ Introduction...............................................................................................1 1.1 Regulatory T cells......................................................................................................2 1.2 Natural regulatory T cells..........................................................................................3 1.3. Inducible regulatory T cells......................................................................................6 1.4. Relationship between CD4+CD25+ T cells, Tr1 cells and Th3 cells........................11 1.5. The role for cytokines in the immune response.......................................................12 1.6. Specific aims............................................................................................................16 Chapter Ⅱ Materials & Methods................................................................................17 2.1. Material....................................................................................................................18 2.2. Methods..............................................................................................................,.....25 Chapter Ⅲ Results.................................................................................................,......36 Chapter Ⅳ Discussion..............................................................................................,,...47 Figures & Tables.........................................................................................................,,.54 References.....................................................................................................................,,76 Appendix......................................................................................................................,,.86 | |
dc.language.iso | en | |
dc.title | 利用DNA微陣列晶片分析研究調節性T細胞的基因表現 | zh_TW |
dc.title | Comparative Studies on the Gene Expression of Regulatory T Cells by DNA Microarray Analysis | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李岳倫,陳進庭 | |
dc.subject.keyword | 調節性T細胞,CD4+CD25+調節性T細胞,誘導型調節性T細胞,第一型調節性T細胞, | zh_TW |
dc.subject.keyword | Regulatory T cell (Treg),Naturally occurring CD4+CD25+Foxp3+ T cell (nTreg),Inducible regulatory T cells (iTreg),Type 1 regulatory T cell (Tr1), | en |
dc.relation.page | 89 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-08-01 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 3.27 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。